Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determination

EuroIntervention. 2020 Nov 20;16(10):787-793. doi: 10.4244/EIJV16I10A147.
No abstract available

MeSH terms

  • COVID-19*
  • Cardiovascular Diseases* / therapy
  • Clinical Trials as Topic
  • Endpoint Determination*
  • Humans
  • Pandemics
  • SARS-CoV-2